Newsletters
2012
May 2012
This issue features a literature highlight on the use of cefpodoxime for uncomplicated cystitis and one on amantadine for traumatic brain injuries. An article on the relationship between statin therapy and diabetes is presented, and one new drug is discussed: Surfaxin® (lucinactant) for respiratory distress syndrome.
April 2012
Drug-induced QT prolongation and the new drug Onfi™ (clobazam) are discussed in this issue. In addition, there are literature highlights on the use of continuous positive airway pressure (CPAP) for metabolic syndrome and the use of cangrelor for bridging antiplatelet therapy in patients undergoing cardiac surgery.
March 2012
Issue Contents: Incivek® (telaprevir), a new medication to be combined with peginterferon alpha plus ribavirin for hepatitis C; cardiovascular risks associated with stimulant use for ADHD in young patients; literature highlights on oral teriflunomide for multiple sclerosis and smoking cessation therapy with cytosine.
February 2012
In this issue, there are literature highlights on the use of atorvastatin for plaque-type psoriasis and the use of saw palmetto for urinary tract symptoms. Also included is an article on Duexis® (ibuprofen and famotidine) and an article on the new treatment guidelines for community-associated methicillin-resistant staphylococcus aureus skin and soft tissue infections.
January 2012
This issue features articles on the 2011-2012 flu vaccine and the status of thiazolidinediones, and literature highlights on Latuda® (lurasidone) for schizophrenia and lebrikizumab for asthma.
2011
December 2011
This issue contains articles on Ferriprox® (deferiprone) for iron overload in thalassemia and Firazyr® (icatibant) for acute attacks of hereditary angioedema. Also in this issue: literature highlights on the effect of early versus late parenteral nutrition in critically ill adults and the use of risperidone in patients with military-related post-traumatic stress disorder.
November 2011
Literature highlights in this newsletter address azithromycin use for preventing COPD exacerbations and omalizumab use for helping uncontrolled asthma. Also discussed is the safety and efficacy of Edurant™ (rilpivirine) for HIV infection and Natroba™ (spinosad) for head lice.
October 2011
This issue features articles on Daliresp™ (roflumilast) for chronic obstructive pulmonary disease and the effects of physical activity on cognitive impairment in the elderly. Also in this issue are literature highlights on the effects of pain treatment on agitation and aggression in dementia and the potential benefits of weekly alendronate and daily vitamin D3 in osteoporosis.
September 2011
This issue features articles on Potiga™ (ezogabine), an option for seizures, and Tradjenta® (linagliptin), a new DPP-4 inhibitor. The literature highlights discuss the efficacy of Dificid™ (fidaxomicin) for Clostridium difficile infection and Edarbi® (azilsartan), a new angiotensin receptor blocker.
August 2011
This issue contains literature highlights comparing amoxicillin to appendectomy for appendicitis and discussing the treatment of hepatitis C with boceprevir in previously treated patients. Other articles discuss the routine use of emergency contraception and a new drug, ipilimumab (Yervoy®), for metastatic melanoma.
July 2011
This issue discusses sustained health risks after stopping long-term treatment with estrogen therapy and dalteparin compared to unfractionated heparin in critically ill patients. As-needed inhaled corticosteroids in treating asthma and an interaction between proton pump inhibitors and aspirin are additional topics.
June 2011
Corifact® (human factor XIII concentrate) for congenital factor XIII deficiency and Viibryd™ (vilazodone) for major depressive disorder are two new drugs discussed in this issue. Also included are literature highlights summarizing studies evaluating the efficacy of an HPV vaccine in males and buprenorphine use for opioid dependence in pregnancy.
May 2011
Polymyxin B treatment of Pseudomonas aeruginosa bacteremia and antibiotic treatment of acute otitis media are discussed in this issue's literature highlights. New drugs evaluated include Halaven® (eribulin mesylate) for breast cancer and Teflaro™ (ceftaroline) for skin and skin-structure infections.
April 2011
Literature highlights in this issue discuss the risk of birth defects associated with proton-pump inhibitors and the hemoglobin A1c-lowering effects of resistance and aerobic exercise. Concerns over caffeinated energy drinks are also addressed.
March 2011
A new drug for schizophrenia, Latuda® (lurasidone), is highlighted in this issue, along with articles discussing counterfeit drugs and sequential therapy for the treatment of Helicobacter pylori infections. Literature highlights examine the effects of docosahexaenoic acid on Alzheimer's disease and the use of naltrexone and sertraline for the treatment of alcohol dependence and co-occuring depression.
February 2011
The effects of a polypill (aspirin, enalapril, atorvastatin, hydrochlorothiazide) on cardiovascular risk factors, ulipristal use in preventing follicular rupture, and fondaparinux for treating superficial-vein thrombosis are literature highlight topics in this issue. The new gout drug Krystexxa® (pegloticase) and the use of S-adenosyl methionine (SAMe) for depression treatment are also discussed.
January 2011
Articles in this issue address the new drug Ampyra® (dalfampridine extended release) for multiple sclerosis and the association of PPIs with Clostridium difficile-associated diarrhea. Literature highlights compare exenatide, pioglitazone, and sitagliptin use as step-2 therapies in type 2 diabetes and cognitive behavioral therapy and relaxation with educational support for attention-deficit/hyperactivity disorder.
2010
December 2010
Fractional-dose polio-virus vaccinations and gastrointestinal adverse events due to celecoxib and diclofenac use are discussed in the literature highlights of this issue. Also included are articles examining hereditary angioedema and the new drug Actemra® (tocilizumab), a medication for rheumatoid arthritis.
November 2010
Literature highlights in this newsletter address antibiotic prophylaxis for PEG tube placement and use of ecallantide for hereditary angioedema. Also discussed is the safety and efficacy of the four-phasic oral contraceptive Natazia™ (estradiol valerate and estradiol valerate/dienogest) and the health benefits of chia seeds.
October 2010
This issue contains articles about needle-free injection devices and treatment of opioid dependence. Literature highlights demonstrate the use of pramipexole for depression and duloxetine for back pain.
September 2010
This issue discusses ondansetron's effects on acetaminophen, the use of everolimus-eluting stents, and the new drugs Lumizyme® (alglucosidase alfa) and Provenge® (sipuleucel-T).
August 2010
The new drug Prolia® (denosumab) and the risk of lung cancer associated with hormone replacement therapy are discussed in this issue, along with literature highlights on vitamin B12 deficiency with metformin use and treatment of hyperemesis gravidarum.
July 2010
This issue includes an article on Victoza® (liraglutide) for type 2 diabetes and the Infectious Diseases Society of America's 10 x '20 Initiative, which calls for the development of 10 new antibiotics by 2020. Also included are literature highlights on a study of atorvastatin in mild to moderate Alzheimer's disease and a comparison of dopamine and norepinephrine for the treatment of shock.
June 2010
Articles in this issue discuss the anti-inflammatory effects of macrolides and the effectiveness of antidepressant medications. Literature highlights discuss studies on topiramate for behavioral disturbances in patients with Alzheimer's disease and control of blood pressure after discontinuation of a pharmacist intervention program.
May 2010
This issue features a literature highlight on darbepoetin alfa in patients with diabetes and chronic kidney disease and one on the comparison between metformin and glyburide in women with gestational diabetes. Two new drugs are also discussed: Sabril® (vigabatrin) and Fanapt™ (iloperidone).
April 2010
The new drugs Vibativ™ (telavancin) and Uloric® (febuxostat) are discussed in this issue. In addition, there are literature highlights on resistance training in patients with multiple sclerosis and high-dose modified-release nicotinic acid for atherosclerosis.
March 2010
Issue Contents: Embeda®, a combination of morphine and naltrexone with lower abuse potential; Intuniv™, extended-release guanfacine for ADHD; literature highlights on HIV vaccination and treatment of glucocorticoid-induced osteoporosis
February 2010
In this issue, there are literature highlights on a cocaine vaccine and the use of darusentan for treatment-resistant hypertension. Also included is an article on Caldolor®, an intravenous formulation of ibuprofen, and an article on Feraheme® (ferumoxytol) for iron deficiency anemia.
January 2010
This issue features an article on Onglyza® (saxagliptin) and an article on the pharmacist's role in pain management. In addition, there are literature highlights on probiotics in children and the use of Tripterygium wilfordii Hook F to treat rheumatoid arthritis.
2009
December 2009
This issue contains articles on Saphris® (asenapine) for schizophrenia and bipolar disease and the use of antipsychotic medications during pregnancy. Also in this issue: literature highlights on the effect of perioperative fluvastatin in patients undergoing non-cardiac vascular surgery and the use of olanzapine in patients with psychotic depression.
November 2009
This issue features articles on the usefulness of probiotics and low-dose naltrexone for multiple sclerosis. Also in this issue are literature highlights on the effect of telmisartan on renal outcomes and dabigatran versus warfarin in patients with atrial fibrillation.
October 2009
This issue features articles on Multaq® (dronedarone) for atrial fibrillation and Effient® (parasugrel) for thrombosis prevention in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). Also in this issue are literature highlights on the effects of soy on bone mineral density in postmenopausal women and the renal and retinal effects of enalapril and losartan in patients with type 1 diabetes.
September 2009
This issue features articles on Dysport®, a competitor of Botox®, and treatments for vitiligo. The literature highlight discusses the safety of enteral naloxone for opiate-induced constipation in the ICU.
August 2009
This issue features articles on Cycloset™ for type 2 diabetes and Latisse® for hypotrichosis. Also in this issue are literature highlights on antivenom for critically ill children following scorpion stings and the effects of cognitive behavioral therapy with or without zolpidem for chronic insomnia.
July 2009
This issue features literature highlights on diabetes education programs and probiotic use in patients after a Roux-en-Y gastric bypass. Also in this issue are articles on besifloxacin suspension for bacterial conjunctivitis and the interaction between clopidogrel and proton pump inhibitors.
June 2009
This issue features articles on medical marijuana and fesoterodine (Toviaz™) for overactive bladder.
May 2009
This issue features literature highlights on maternal influenza vaccination to prevent influenza in infants, the effects of high-dose DHA supplementation on the neurodevelopment of preterm infants, and the risk of developing age-related macular degeneration in women taking folic acid, pyridoxine, and cyanocobalamin.
March 2009
This issue features articles on tapentadol for moderate to severe pain and milnacipran (Savella®) for fibromyalgia, and literature highlights on topical pexiganan cream for infected diabetic foot ulcers and the comparison of first-generation versus second-generation antipsychotics for children and adolescents with early-onset schizophrenia and schizoaffective disorder.
February 2009
This issue features articles on Cinryze® for hereditary angioedema and using Wikipedia for health information, and literature highlights on the use of surfactant in lung transplantation and the effect of a low-glycemic index diet on type 2 diabetes.
January 2009
This issue features articles on the effect of long-term hormonal contraception on fertility and Viagra® for female sexual dysfunction, and a literature highlight on evaluating blood viscosity and hematocrit as risk factors for type 2 diabetes.
2008
December 2008
This issue features an article on the link between serum fatty acid concentrations and ADHD, and literature highlights on the use of continuous glucose monitoring in type 1 diabetes and the absence of anticoagulation in PCI.
November 2008
This issue features articles on bisphenol A (BPA) and the resurgence of rickets, and literature highlights on nicotine nasal spray in adolescents for smoking cessation and PEG3350 for childhood constipation.
October 2008
This issue features articles on rivaroxaban for thromboprophylaxis and male hormonal contraception, and literature highlights on testosterone in males with schizophrenia and lubiprostone for bowel cleansing prior to colonoscopy.
September 2008
This issue features a literature highlight on rivaroxaban for thromboprophylaxis following hip arthroplasty and articles on the new guidelines for hyperlipidemia in children, the black box warning on conventional antipsychotics, and using estimated average glucose to monitor glucose control
August 2008
This issue features an article on naturopathic physicians and literature highlights on postoperative ketamine to decrease morphine use, duloxetine for fibromyalgia, and the effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control.
July 2008
This issue features articles on the Rotarix® vaccine for infants and children and Entereg® (alvimopan) for post-operative ileus, and literature highlights on pharmacist- versus physician-obtained medication histories and the use of home automated external defibrillators for sudden cardiac arrest.
June 2008
This issue features articles on continuous glucose monitors and medical identity theft.
May 2008
This issue features an article on extended-cycle oral contraceptives and literature highlights on home-based exercise for heart failure and fluoxetine with or without cognitive behavioral therapy in adolescents with depression.
April 2008
This issue features a literature highlight on topiramate for alcohol dependence and articles on the risk of hearing loss with erectile dysfunction drugs, Abilify® for treatment-resistant major depressive disorder, and the bizarre behavior reported with Chantix®.
March 2008
This issue features articles on Cimza® (certolizumab) for Crohn’s Disease and the FDA cracking down on unapproved drugs, and literature highlights on perindopril in patients with Marfan syndrome and prednisolone or acyclovir for Bell’s palsy.
February 2008
This issue features articles on the current state of sliding scale insulin and Azor® (amlodipine and olmesartan medoxomil) for hypertension, and literature highlights on dabigatran for prevention of venous thromboembolism following total hip replacement and the effect of lowering homocysteine on mortality in patients with chronic kidney disease.
January 2008
This issue features articles on Selzentry® (maraviroc) for HIV and Risperdal® approved for pediatrics, and literature highlights on immune function in children exposed to immunosupressants in utero and the use of carvedilol in children with heart failure.
2007
December 2007
This issue features articles on the updated 2007 asthma guidelines, childhood vaccination requirements, and literature highlights on womens health issues
November 2007
Literature Highlight: Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
October 2007
Literature Highlight: A Chocolate a Day Keeps Hypertension Away?
September 2007
The Effect of Acetaminophen on the International Normalized Ratio in Patients Stabilized on Warfarin Therapy
August 2007
Pregnancy Outcomes with Iron Supplementation in Women Who Are Not Anemic
July 2007
Once-Yearly Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis
June 2007
Levosimendan or Dobutamine for Acute Decompensated Heart Failure
May 2007
Paliperidone Extended-Release Tablets for Prevention of Recurrence in Patients with Schizophrenia
April 2007
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
March 2007
Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol
February 2007
Efficacy and Safety of Rosuvastatin Every Other Day Compared with Once Daily in Patients with Hypercholesterolemia
January 2007
Orlistat for Mild to Moderately Overweight Individuals
2006
December 2006
Incidence of Diabetes in High-Risk Populations Given Rosiglitazone
November 2006
If Plan A Fails, Go To Plan B®
October 2006
Does Celecoxib Potentiate the Anticoagulation Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial
September 2006
The Use of Fluoxetine and Light therapy in Seasonal Affective Disorder
August 2006
Oral Sunscreen: Take One Tablet Daily?
July 2006
Literature Highlight: Risk of Major Congenital Malformations After First-Trimester Exposure to ACE Inhibitors
June 2006
Literature Highlight Ability of Practitioners to Identify Solid Oral Dosage Tablets
May 2006
Vitamin D and Calcium Reduce Falls
April 2006
The Methylphenidate Patch (Daytrana®): A New Drug Delivery System
March 2006
Antibiotic-Laden Cement used in Revision Surgery of Infected Joint Arthroplasty
February 2006
Exjade® (deferasirox): Oral Iron Chelator
January 2006
Nepafenac (Nevanac™) - A Pain in the Eye
2005
December 2005
Lipitor® (atorvastatin) Every Other Day
November 2005
A New Program for the Safe Use of Accutane®
October 2005
Childhood Obesity: A Growing Problem
September 2005
Zostavax™ (varicella zoster vaccine): The Elderly Get Stuck (To Prevent Shingles)
August 2005
Recommendations for a Skin Cancer Self Exam
July 2005
Tapering Antidepressants to Avoid Withdrawal
June 2005
Xifaxan™ (rifaximin) for Traveler’s Diarrhea
May 2005
Clofarabine For Pediatric Refractory Relapsing Acute Lymphoblastic Leukemia
April 2005
Lunesta™ (eszopiclone): For Insomnia
March 2005
The “Skinny” on CortiSlim™
February 2005
Bleeding Risk Associated with SSRIs
January 2005
Pfizer Warns of the Serious Risks Associated with Bextra®
2004
December 2004
Overnight Contact Lenses for Corneal Reshaping
November 2004
Cymbalta® (duloxetine): A new SNRI for depression
October 2004
Ghrelin: A New Weight Regulation Peptide
September 2004
Rimonabant: For obesity and smoking cessation
August 2004
Women’s Health Initiative: Effects of Estrogen-Alone in Postmenopausal Women With Hysterectomy
July 2004
Antidepressants and the risk of suicide among children and adolescents
June 2004
Fabry Disease and the New Treatment, Agalsidase beta
May 2004
Transdermal Selegiline (Emsam®) in Major Depression
April 2004
Levosimendan: A Positive “Inodilator” Prospect
March 2004
Rosuvastatin (Crestor®)
February 2004
Integrative Therapies for Osteoarthritis
January 2004
Memantine for Moderate to Severe Alzheimer’s
